Site icon Hot Paths

InMode estimates Q4 revenue below consensus (NASDAQ:INMD)

  • Medical technologies company InMode (NASDAQ:INMD) expects Q4 revenue to be in the range of $97.0M to $97.5M, vs. consensus of 117.83M.
  • The full-year 2024 revenue is estimated to be in the range of $394.0M to $394.5M, vs. consensus of $411.19M.
  • Full-year 2025
Exit mobile version